140 related articles for article (PubMed ID: 23531999)
21. CEUS of the pancreas: Still research or the standard of care.
D'Onofrio M; Canestrini S; De Robertis R; Crosara S; Demozzi E; Ciaravino V; Pozzi Mucelli R
Eur J Radiol; 2015 Sep; 84(9):1644-9. PubMed ID: 25796427
[TBL] [Abstract][Full Text] [Related]
22. Quantitative contrast-enhanced harmonic endoscopic ultrasonography for the discrimination of solid pancreatic masses.
Seicean A; Badea R; Stan-Iuga R; Mocan T; Gulei I; Pascu O
Ultraschall Med; 2010 Dec; 31(6):571-6. PubMed ID: 21080306
[TBL] [Abstract][Full Text] [Related]
23. Role of contrast-enhanced ultrasound with time-intensity curve analysis for differentiating hypovascular solid pancreatic lesions.
Wang L; Nie F; Dong T; Li M; Li Y; Yin C
Eur Radiol; 2023 Jul; 33(7):4885-4894. PubMed ID: 36725721
[TBL] [Abstract][Full Text] [Related]
24. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
25. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography.
D'Onofrio M; Zamboni G; Tognolini A; Malago R; Faccioli N; Frulloni L; Pozzi Mucelli R
World J Gastroenterol; 2006 Jul; 12(26):4181-4. PubMed ID: 16830370
[TBL] [Abstract][Full Text] [Related]
26. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging.
Sofuni A; Iijima H; Moriyasu F; Nakayama D; Shimizu M; Nakamura K; Itokawa F; Itoi T
J Gastroenterol; 2005 May; 40(5):518-25. PubMed ID: 15942718
[TBL] [Abstract][Full Text] [Related]
27. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses.
D'Onofrio M; Megibow AJ; Faccioli N; Malagò R; Capelli P; Falconi M; Mucelli RP
AJR Am J Roentgenol; 2007 Dec; 189(6):1435-42. PubMed ID: 18029882
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
30. Added value of intravenous contrast-enhanced ultrasound for characterization of cystic pancreatic masses: a prospective study on 37 patients.
Vasile TA; Socaciu M; Stan Iuga R; Seicean A; Iancu C; al Hajjar N; Zaharie T; Badea R
Med Ultrason; 2012 Jun; 14(2):108-14. PubMed ID: 22675710
[TBL] [Abstract][Full Text] [Related]
31. Contrast enhanced ultrasound and computer tomography diagnosis of solid and mixed pancreatic tumors - analysis of confounders.
Vasile TA; Feier D; Socaciu M; Anton OM; Seicean A; Iancu C; Zaharie T; Badea R
J Gastrointestin Liver Dis; 2012 Sep; 21(3):285-92. PubMed ID: 23012670
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy.
Rickes S; Unkrodt K; Ocran K; Neye H; Wermke W
Pancreas; 2003 Jan; 26(1):76-81. PubMed ID: 12499921
[TBL] [Abstract][Full Text] [Related]
33. Guiding and controlling percutaneous pancreas biopsies with contrast-enhanced ultrasound: target lesions are not localized on B-mode ultrasound.
Wei Y; Yu XL; Liang P; Cheng ZG; Han ZY; Liu FY; Yu J
Ultrasound Med Biol; 2015 Jun; 41(6):1561-9. PubMed ID: 25819468
[TBL] [Abstract][Full Text] [Related]
34. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography.
Yamada S; Fujii T; Suzuki K; Inokawa Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2016 Feb; 45(2):198-203. PubMed ID: 26390421
[TBL] [Abstract][Full Text] [Related]
36. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced ultrasonograpic findings in pancreatic tumors.
Recaldini C; Carrafiello G; Bertolotti E; Angeretti MG; Fugazzola C
Int J Med Sci; 2008 Jul; 5(4):203-8. PubMed ID: 18645620
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors.
Rickes S; Mönkemüller K; Malfertheiner P
JOP; 2006 Nov; 7(6):584-92. PubMed ID: 17095837
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study.
Gupta P; Rana P; Marodia Y; Samanta J; Sharma V; Sinha SK; Singh H; Gupta V; Yadav TD; Sreenivasan R; Vaiphei K; Rajwanshi A; Kochhar R; Sandhu M
Eur Radiol; 2022 Oct; 32(10):6668-6677. PubMed ID: 35587829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
